Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Denham

Showing results (251-260 of 275) with videos related to

Pageof 28
Sort By:
Histopathology|April 15, 2020
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR TrialBrett Delahunt, Judith D Murray, Allison Steigler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2012
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancerJames W Denham, Chantelle Wilcox, David S Lamb, et al.
The Lancet. Oncology|November 16, 2012
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trialJames W Denham, Chantelle Wilcox, David Joseph, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patientsAlessandro Cicchetti, Claudio Fiorino, Martin A Ebert, et al.
Pathology|December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trialB Delahunt, A Steigler, C Atkinson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2011
MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planningJonathan Lambert, Peter B Greer, Fred Menk, et al.
The Lancet. Oncology|December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|November 1, 2005
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trialJames W Denham, Allison Steigler, David S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancerDavid S Lamb, James W Denham, Hedy Mameghan, et al.
Pageof 28

Showing results (251-260 of 275) with videos related to

Sort By:
Pageof 28
Histopathology|April 15, 2020
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR TrialBrett Delahunt, Judith D Murray, Allison Steigler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2012
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancerJames W Denham, Chantelle Wilcox, David S Lamb, et al.
The Lancet. Oncology|November 16, 2012
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trialJames W Denham, Chantelle Wilcox, David Joseph, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patientsAlessandro Cicchetti, Claudio Fiorino, Martin A Ebert, et al.
Pathology|December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trialB Delahunt, A Steigler, C Atkinson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2011
MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planningJonathan Lambert, Peter B Greer, Fred Menk, et al.
The Lancet. Oncology|December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|November 1, 2005
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trialJames W Denham, Allison Steigler, David S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancerDavid S Lamb, James W Denham, Hedy Mameghan, et al.
Pageof 28